Average Co-Inventor Count = 4.75
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Patent Gmbh (8 from 2,937 patents)
2. Pierre Fabre Medicament (6 from 266 patents)
3. Calypso Biotech Sa (3 from 3 patents)
4. Merck Serono S. A. (2 from 145 patents)
5. Biomunex Pharmaceuticals (2 from 4 patents)
6. Ares Trading S.a. (1 from 135 patents)
21 patents:
1. 11884724 - Anti-PD-L1 antibodies and uses thereof
2. 11773159 - Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same
3. 11560437 - Stable multispecific antibodies
4. 11505616 - Binding molecules to CD38 and PD-L1
5. 11130806 - Antibodies to IL-15 and uses thereof
6. 10829552 - Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same
7. 10759856 - Anti-PD-L1 antibodies and uses thereof
8. 10487147 - Anti-PD-L1 antibodies and uses thereof
9. 10364296 - Antibodies specific for MMP9
10. 10301384 - Antibodies to IL-15
11. 10017568 - Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using same
12. 9624298 - Anti-PD-L1 antibodies and uses thereof
13. 9567397 - Antibody with specificity for GM-CSF (I)
14. 9567398 - Antibody with specificity for GM-CSF (II)
15. 9534054 - Monoclonal antibody directed against CXCR5